(MedPage Today) — Note that some links may require registration or subscription.
Semaglutide (Wegovy) cut the risk for major heart events in people with obesity and cardiovascular disease regardless of how much weight they lost. (The Lancet…
Source link : https://www.medpagetoday.com/primarycare/obesity/118099
Author :
Publish date : 2025-10-23 13:25:00
Copyright for syndicated content belongs to the linked Source.
